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ABSTRACT
Prevalence of tooth extraction or dental surgery was 48.5% of all dental care in Indonesia. Tooth extraction carries
potential health risks and side effects such as pain, swelling, trismus and dysfunction of the oral cavity during
recovery. Secretory leukocyte protease inhibitor (SLPI) is one of innate immunity proteins that can inhibit the
activation of macrophages. We are expecting the provision of SLPI can decrease excessive inflammatory response
in healing after tooth extraction. This study was to investigate the administration of SLPI on cellular expression of
NF-Kβ and IL-1β on wound macrophages of Rattus novergicus post tooth extraction. The research design is in
vivo  experimental  study.  In  total,  20  rats  were  randomly  divided  into  four  groups  (each  group  n=5)  and
underwent  tooth  extraction  on  left  incisor  teeth  of  mandible.  One  of  the  groups  did  not  receive  SLPI
administration (control group) and the socket was stitched after tooth extraction. Meanwhile, the remaining three
groups (experimental groups) were given SLPI administration after tooth extraction with three different doses (0.1
µM, 0.5 µM and 2.5 µM, respectively). After SLPI administration, the socket of experimental groups was stitched.
The effects of SLPI administration were evaluated by counting at the percentage of NF-Kβ translocation and the
expression of expression of IL-1 in macrophages cells of the rat socket using immunohistochemistry analysis. The
cellular expression of NF-Kβ and IL-1β were significantly decreased (p < 0.05) on groups with SLPI may decrease
cellular expression of NF-Kβ and IL-1  β on wound macrophages cells of rats post tooth extraction in a dose-
dependent manner.
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Tooth extraction is the removal of teeth from the
dental alveolus (socket) in the bone which is the most
widely performed by dentist.  According to survey by
RISKESDAS 2007 [1], the prevalence of tooth extrac-
tion or dental surgery was 48.5% of all dental care in
Indonesia.  Tooth  extraction  carries  potential  health
risks and side effects  such as  pain,  swelling,  trismus
and a general dysfunction of the oral cavity during re-
covery.
Post tooth extraction,  the wound induces  platelet
aggregation  and  produces  chemokine to  attract  neu-
trophils in the lesion. After 48 hours, neutrophils un-
dergo  apoptosis  and  replaced  by  macrophages.
Macrophages will be actively induced by LPS bacteria
residing around the lesion in the mouth and stimulate
the activation of macrophages into the lesion. Activated
macrophages secrete proinflamatory cytokines, such as
Tumor  Necrosis  Factors  α (TNF-α),  interleukin-1
(IL1), interleukin-6 (IL6), interleukin-8 (IL8) and inter-
leukin-12  (IL12) [2].  In  the  prolonged  inflammation
and  delayed  wound  healing,  activated  macro-phages
may  secrete  excessive  cytokines  such  as  TNF-α  and
IL1. Thus, it may lead to excessive inflammation.
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Secretory leukocyte protease inhibitor (SLPI) is  a
cationic protein with 11.7 kDa and one of innate im-
munity  proteins.  SLPI  is  a  non-glycosylated  protein,
acid-stable,  cysteine-rich,  107-amino  acid  and  single
chain polypeptide [3]. Some studies showed that mice
deficient SLPI or SLPI gene deletions may cause impair
or delay wound healing [4, 5]. It has been known that
SLPI may down regulated macrophage response to bac-
terial  lipopolysaccharide (LPS) [3].  In vitro study by
Sano et al. (2003) [6] found that SLPI may inhibit the
activation of NF-K  β and TNF- α in macrophages that
was stimulated by LPS. Other studies also performed
that administration of SLPI may inhibit the secretion
of TNF-α inflammatory mediators in spinal cord injury
and arthritis  [7,  8].  Decreasing expression of IL1 by
macrophages may accelerate the lesion entering prolif-
erative phase of healing through increased the synthe-
sis of fibroblasts, collagen and ECM.
The aim of this study was to investigate the effect
of SLPI administration on pro-inflammatory cytokines
post tooth extraction using in vivo models of  Rattus
novergicus by  counting  at  the  precentage  of  NF-Kβ
and IL1 on activated macrophage cells. 
Ethics
This  research  was  approved  by  Health  Research
Ethics Commission from Faculty of Medicine, Brawi-
jaya  University,  Indonesia  with  ethical  number
355/EC/KEPK-S2/06/2015
Chemicals
SLPI was used in this experiment is a Human Re-
combinant  SLPI  (R&D system,  1274-PI).  Antibodies
anti-NF-kB/p65  Ab-1  (LOT:  1638P8031,  Neomarker)
and anti-IL-1β antibody (7884, Santa Cruz).
Research design
The research design is in vivo experimental study
that using Randomized Post Test Only Control Group
Design.  In total,  20 rats were randomly divided into
four groups (each group n=5) and underwent tooth ex-
traction on left incisor teeth of mandible. One of the
groups  did  not  receive  SLPI  administration  (control
group) and the socket was stitched after tooth extrac-
tion. Meanwhile, the remaining three groups (experi-
mental  groups) were given SLPI administration after
tooth extraction with three different doses (0.1 µM, 0.5
µM, and 2.5 µM, respectively). After SLPI administra-
tion, the socket of experimental groups was stitched.
The effects of SLPI administration were evaluated by
counting at the percentage of expression  NF-K  β and
IL-1 in macrophages cells of the rat socket. 
Tooth extraction of rats
R.  norvegicus were  anesthetized  intraperitoneally
by  mixing  Ketalar  (60  mg/kg)  and  Diazepam  (10
mg/kg) using syringe (1 mL).  Then,  the rats  under-
went  aseptic  on their  extraction site.  Mandibular  in-
cisor tooth extraction is done by using clamp that is
specifically modified for rat tooth extraction. After lux-
ation the teeth using Lecron that is modified as being,
the teeth was clamped with clamp and extracted.
SLPI administration
SLPI  was  given  post  tooth  extraction  on the  rat
socket. The experimental groups received SLPI 0.1 µM,
0.5 µM, and 2.5 µM, respectively using specific pipette
after the socket is cleaned up by gauze. The wound was
stitched with silk,  half  moon needle  (Mani  1.8)  and
needle  holder.  Meanwhile,  the  control  group  under-
went  stitched  socket  after  tooth  extraction  without
SLPI administration. 
Sampling
After 5 days of tooth extraction, the rats were sacri-
ficed, the mandible of rats were put into a tube con-
taining 10% of formalin for tissue fixation, then soaked
in 14% EDTA for 30 days and labeled.
IHC staining
After HPA preparation, IHC staining was done by
IHC  kit,  NF-Kβ (anti-NF-Kβ/p65  Ab-1
LOT:1638P8031, Neomarker) and IL-1  β antibody (IL-
1  β anti-7884,  Santa  Cruz)  on  the  slide.  The  results
were observed under the light microscope with 400×
magnification. Cellular expression of NF-K   β p65 sub-
unit  was  obtained  by  counting  the  number  of
macrophages  that  was  detected  by  kromagen  DAB
(brown) in the cytoplasm and nucleus, in the form of
the  average  percentage  in  10 visual  field  (Figure  1).
Cellular expression of IL-1  β was obtained by the num-
ber  of  macrophages  that  was  detected  by  kromagen
DAB (brown) in the cytoplasm and around cells, in the
form of the average percentage in 10 visual field  (Fig-
ure 3).
Statistical analysis
All data are presented as mean ± SD. The statistical
analysis was performed using the  IBM SPSS Statistic
20 Windows (IBM Corp., Armonk, NY, USA). Differ-
ences  between  groups  were  determine  by One Way 
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Figure 1. IHC staining:  Cellular  expression  of  NF-K  β (C  =
Control;  D1 = Treated with dose 1 (0.1µM); D2 =
Treated with dose 1 (0.5µM); and D3 = Treated with
dose 1 (2,5µM))
ANOVA test,  followed by Post-Hoc test.  Correlation
analyses between variables were evaluated using Core-
lation-Regresion test. Group differences at the level of
p < 0.05 were considered statistically significant.
The effects of SLPI on NF- K β cellular expression
The  highest  percentage  (38.86%)  of  macrophage
cells  that  expressed  NF-K  β was  detected  in  control
group.  Inversely,  the  lowest  percentage  (18.77%)  of
macrophage cells that expressed NF- K  β was found in
the experimental group with highest dose of SLPI (2.5
µM) (Figure 2). Both of groups (control group vs ex-
perimental group with SLPI 2.5  µM shows significant
difference (p = 0.00).  Pearson correlation shows that
there  was  significantly  strong  relationship  between
SLPI concentration and the percentage of macrophage
cells that expressed NF-K . β This finding suggested that
SLPI concentration was negatively associated with cel-
lular expression of NF-K .β
The effects of SLPI on IL-1β cellular expression
The  highest  percentage  (51.10%)  of  macrophage
cells that expressed IL-  β was observed in control group.
However,  the  lowest  percentage  (23.52%)  of
macrophage cells that expressed IL-  β was detected in
the experimental group with highest dose of SLPI (2.5
µM) (Figure 4). Both of groups (control group vs ex-
perimental group with SLPI 2.5  µM shows significant
difference (p = 0.00).  Pearson correlation shows that
there  was  significantly  strong  relationship  between
SLPI concentration and the percentage of macrophage
cells that expressed IL-1 . β This finding suggested that 
Figure 2. Percentage of macrophage cells as cellular expression
of NF-K  β (C = Control; D1 = Treated with dose 1
(0.1µM); D2 = Treated with dose 1 (0.5µM); and D3
= Treated with dose 1 (2,5µM))
SLPI concentration was negatively associated with cel-
lular expression of IL-β (p = -0.906).
Pearson  correlation  demonstrates  that  there  was
significantly strong relationship between the expression
of cellular NF-K  β and IL-  β (p = 0.954). The positive as-
sociation was also observed between the expression of
NF-K  β and IL- .β
Macrophages are the cells that normally involved in
wound healing. Initially, macrophages produce proin-
flammatory cytokines and modulate inflammatory re-
sponse  by  recruiting  and  activating  leukocytes.  LPS
stimulate macrophages and activate transcription fac-
tor. Activation of NF- K  β has been associated with the
production of TNF-α, IL-1, IL-6, IL-8, COX2, intracel-
lular adhesion molecules (ICAM)-1 and kolagenase [9].
Our study showed that the highest cellular expres-
sion of  NF-K  β and  IL-1β was  found in  the  control
group that did not receive SLPI post tooth extraction.
Physical trauma and tissue injury after tooth extraction
may activate transcription factor NF-K .  β Lipopolysac-
charide (LPS) of bacteria, the endotoxin produced by
gram-negative  bacteria  which are  located  around the
wound can be recognized by the TLR4 and stimulate
pro-inflammatory by macrophages and activate signal-
ing pathways for transcription factor NF-Kβ [10]. In-
creased  activation  of  NF-Kβ through  the  canonical
pathway caused by tooth extraction in rats may induce
the secretion of pro inflammatory cytokines (IL-1β).
In the prolonged inflammation and delayed wound
healing, activated macrophage will secrete excessive IL-
1β that lead to excessive inflammation and may inter-
fere the balance of inflammation.  A small amount of
IL-1  is  necessary  for  the  body's  defense  and  wound
healing, but excessive IL-1 may inhibit the early phase
of wound healing [11, 12].
Our study also observed that there was significantly
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Figure 3. IHC staining: Cellular expression of IL-1  β (C = Con-
trol; D1 = Treated with dose 1 (0.1µM); D2 = Treated
with dose 1 (0.5µM); and D3 = Treated with dose 1
(2,5µM))
decreased in cellular expression of NF-K  β and IL-1  β by
administration of SLPI. The amount of cellular expres-
sion of NF-  β and IL-1  β were negatively associated with
the doses of SLPI. The most significant decreased in
cellular expression of NF-K  β and IL-1  β was found in
experimental group with SLPI of 2.5 µM. In line with
previous study by Murata et al. (2003) [13] found that
SLPI administration topically inhibit the development
allergies conjungtivitis.
Previous  research  demonstrated  that  SLPI  may
down regulate the activation of macrophage to bacte-
rial lipopolysaccharide (LPS). SLPI bind to annexin II
receptors  which  located  on  the  cell  surface  of
macrophages and may inhibit the activation and down-
stream of NF-K  β through protection inhibitor of kappa
(I-Kβ)  from degradation by the ubiquitin proteosom
pathway [14, 15, 16]. Additionally, SLPI may compete
with NF-K  β (p65) to bind with the binding site of NF-
K  β in  nukleus  [17].  Thus,  SLPI  may  inhibit
macrophage  activation  and  prevent  the  secretion  of
proinflammatory cytokines such as TNF-α, IL1 and ni-
tric oxide (NO). In vitro study by Sano et al. (2003) [6]
showed that SLPI inhibit activation of NF-K  β and pro-
duction  of  IL-1  in  macrophages  stimulated  by  LPS.
Several other studies also observed that administration
of SLPI inhibits the secretion of inflammatory media-
tors TNF-α in spinal cord injury and arthritis [7, 8].
Recently, NF-K  β has been widely known as a key
target  of  anti-inflammatory  drug.  However,  genetic
studies in rats have demonstrated that targeting NF-Kβ
was  problematic  in  inflammatory  diseases.  NF-Kβ
pathways may regulate the production of pro-inflam-
matory cytokines, leukocyte recruitment, or survival of
cells, which play an important role in the inflammatory
res-
Figure 4. Percentage of macrophage cells as cellular expression
of  IL-1  β (C = Control;  D1 = Treated with dose 1
(0.1µM); D2 = Treated with dose 1 (0.5µM); and D3
= Treated with dose 1 (2,5µM))
ponse [10].  However, the apoptotic function of NF-Kβ
also protect against inflammation in the case of epithe-
lial  cell  survival  and  mucosal  barrier.  The  apoptotic
functions  of  NF-K  β keep the  inflammatory  response
through  activation  of  leukocytes  persistenly.  In  con-
trast, NF-K  β may promote apoptosis of leukocytes in a
particular context that may contribute to the resolution
of inflammation. It is clear that NF-K  β controlling in-
flammation  through  a  variety  of  mechanisms  [10].
Thus, further studies are required to evaluate the acti-
vation of NF-K  β pathway as a therapeutic target. 
In conclusion, the present data confirm that SLPI
may decrease cellular expression of NF-K  β and IL-1β
on wound macrophages cells of rats post tooth extrac-
tion in a dose-dependent manner.
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